1. Air pollution associate with advanced hepatic fibrosis among patients with chronic liver disease
- Author
-
Jang, Tyng‐Yuan, Ho, Chi‐Chang, Liang, Po‐Cheng, Wu, Chih‐Da, Wei, Yu‐Ju, Tsai, Pei‐Chien, Hsu, Po‐Yao, Hsieh, Ming‐Yen, Lin, Yi‐Hung, Hsieh, Meng‐Hsuan, Wang, Chih‐Wen, Yang, Jeng‐Fu, Yeh, Ming‐Lun, Huang, Chung‐Feng, Chuang, Wan‐Long, Huang, Jee‐Fu, Cheng, Ya‐Yun, Dai, Chia‐Yen, Chen, Pau‐Chung, and Yu, Ming‐Lung
- Abstract
We aimed to investigate the association between air pollution and advanced fibrosis among patients with metabolic associated fatty liver disease (MAFLD) and chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. A total of 1376 participants who were seropositive for HBV surface antigen (HBsAg) or antibodies to HCV (anti‐HCV) or had abnormal liver function in a community screening program from 2019 to 2021 were enrolled for the assessment of liver fibrosis using transient elastography. Daily estimates of air pollutants (particulate matter ≤2.5 μm in diameter [PM2.5], nitrogen dioxide [NO2], ozone [O3] and benzene) were aggregated into mean estimates for the previous year based on the date of enrolment. Of the 1376 participants, 767 (52.8%) and 187 (13.6) had MAFLD and advanced fibrosis, respectively. A logistic regression analysis revealed that the factors associated with advanced liver fibrosis were HCV viremia (odds ratio [OR], 3.13; 95% confidence interval [CI], 2.05–4.77; p< 0.001), smoking (OR, 1.79; 95% CI, 1.16–2.74; p= 0.01), age (OR, 1.04; 95% CI, 1.02–1.05; p< 0.001) and PM2.5(OR, 1.10; 95% CI, 1.05–1.16; p< 0.001). Linear regression analysis revealed that LSM was independently correlated with PM2.5(β: 0.134; 95% CI: 0.025, 0.243; p= 0.02). There was a dose‐dependent relationship between different fibrotic stages and the PM2.5level (the PM2.5level in patients with fibrotic stages 0, 1–2 and 3–4: 27.9, 28.4, and 29.3 μg/m3, respectively; trend p< 0.001). Exposure to PM2.5, as well as HBV and HCV infections, is associated with advanced liver fibrosis in patients with MAFLD. There was a dose‐dependent correlation between PM2.5levels and the severity of hepatic fibrosis.
- Published
- 2024
- Full Text
- View/download PDF